alexa The relationship between visfatin and metabolic syndrome in postmenopausal women.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Kim JH, Kim SH, Im JA, Lee DC, Kim JH, Kim SH, Im JA, Lee DC

Abstract Share this page

Abstract OBJECTIVE: The biological role and activity of visfatin, an adipokine mainly produced by visceral fat, has not been fully elucidated. The observed relationships between visfatin and metabolisyndrome are inconsistent. The purpose of this study was to illuminate the relationship between visfatin and metabolic syndrome in postmenopausal women. METHODS: The present study included a sample of 110 postmenopausal Korean women. Subjects with cardiovascular disease or uncontrolled diabetes were excluded from the study sample. Body weight, height, blood pressure (BP), and waist and hip circumference were measured, and biochemical tests were performed. RESULTS: The mean serum visfatin level (mean+/-SD) of subjects with metabolic syndrome was 2.74+/-1.70 ng/ml. This was significantly higher than the mean level of subjects without metabolic syndrome (p<0.01). As the number of components of metabolic syndrome increased, the concentration of serum visfatin also increased (p<0.01). Visfatin concentration was positively correlated with age (r=0.209, p<0.05), waist circumference (r=0.261, p<0.01), systolic BP (r=0.255, p<0.01), diastolic BP (r=0.252, p<0.01), fasting glucose level (r=0.278, p<0.01), fasting insulin level (r=0.313, p<0.01), HOMA-IR (r=0.345, p<0.01), total cholesterol level (r=0.213, p<0.05), triglyceride level (r=0.368, p<0.01), WBC count (r=0.352, p<0.01), and homocysteine level (r=0.196, p<0.05). Using a multiple logistic regression analysis, visfatin was found to be an independent factor associated with metabolic syndrome after an adjustment for confounding variables including age, body mass index (BMI), and HOMA-IR. CONCLUSIONS: Serum visfatin was associated with metabolic syndrome in postmenopausal women. This suggests that visfatin may act as the underlying pathophysiological trigger for metabolic syndrome in postmenopausal women. Copyright 2010 Elsevier Ireland Ltd. All rights reserved. This article was published in Maturitas and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords